The federal government's allegations that AmerisourceBergen Corporation (ABC), one of the nation's largest wholesale drug companies, illegally repackaged injectable drugs from overfill for cancer patients has resulted in a $625 million settlement.
ABC's actions were an attempt to profit from drug "overfill" by establishing a pre-filled syringe program through a subsidiary the ABC said was a pharmacy but was actually a repacking operation, according to the DOJ.